COURT-RULING ·Filed Jun 29, 2026

FMS

Fresenius Medical Care AG
NEUTRAL
Impact 1/10
Horizonimmediate Processed3mo ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

No material impact on FMS stock is expected from this routine individual-case dismissal. The filing confirms the absence of any pending material litigation risk from this matter. Continue monitoring for larger regulatory or operational developments in the dialysis sector.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
FMS ▼ -0.88% at T+60d
NEUTRAL call ✗ call lost -0.88% · α vs SPY -5.27% · entry $22.70 → $22.50
Entry anchored
Jun 26, 03:59 PM ET
via exchange tick
T+1d
-0.40%
call -0.40% · α -1.18%
$22.61
settled 3mo ago
T+5d
+4.01%
call +4.01% · α +2.62%
$23.61
settled 3mo ago
T+20d
+8.33%
call +8.33% · α +8.61%
$24.59
settled 2mo ago
T+60d
-0.88%
call -0.88% · α -5.27%
$22.50
settled 10d ago

Price Chart

Loading chart...

Executive Summary

Fresenius Medical Care AG (FMS) scored a complete dismissal of a pro se employment/ discrimination/RICO lawsuit against its subsidiary Fresenius Kidney Care Pearland. The federal claims were dismissed with prejudice and state claims without prejudice. This removes a trivial litigation overhang that posed no material financial exposure to the $12.8B company.

Court Ruling Details

Ruling Date
Jun 29, 2026
Court
United States District Court, Southern District of Texas, Houston Division
Court Level
District
Judge
Charles Eskridge
Case Type
employment
Ruling Type
motion to dismiss
Outcome
WIN — ruling favors this company
Will It Be Appealed?
Unlikely
Precedent Risk
LOW

Key Facts

  • Plaintiff Jerry Jerome Harris brought disability, race, sex, sexual harassment, retaliation, RICO, and state-law claims against a Fresenius subsidiary.
  • The district court adopted the magistrate judge's recommendation to dismiss all federal claims with prejudice and state claims without prejudice.
  • Plaintiff's objections were overruled and his request for leave to amend was denied.
  • No damages or financial exposure is stated anywhere in the ruling; the case is a routine individual employment dispute with no class, injunction, or precedent implications.

Financial Impact

No damages awarded or sought stated in the opinion. The case is an individual pro se employment suit with de minimis exposure for a $12.8B company.

Risk Factors

  • No material litigation risk identified from this case.

Market Snapshot

Exchange
OTC
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
42% bullish (26 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-h4uj586q-FMS
8 reports for FMS
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+60▲ +3.43%Apr 7, 2026
Filters
Rows
Reports for FMS — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
Court Ruling
NEUTRAL ★ 1/10
$22.74 $22.38▼ −1.58%▼ −1.90%$22.25 (−2.15%)
Aug 31, 2026
4w ago
Court Ruling
NEUTRAL ★ 4/10
$22.74 $22.27▼ −2.07%▼ −1.88%$22.25 (−2.15%)
Aug 27, 2026
5w ago
6-K
BULLISH ★ 5/10
$23.27 $22.35▼ −3.95%▼ −3.45%$22.25 (−4.38%)
Aug 4, 2026
8w ago
6-K
MIXED ★ 5/10
$24.01 $22.74▼ −5.29%▼ −4.05%$22.25 (−7.33%)
Jun 29, 2026
13w ago
Court Ruling
NEUTRAL ★ 1/10
$22.70 $24.59▲ +8.33%▲ +8.61%$22.25 (−1.98%)
Apr 7, 2026
25w ago
Court Ruling
BULLISH ★ 7/10
$22.75 $22.65▼ −0.44%▼ −10.22%$22.25 (−2.20%)
Mar 30, 2026
26w ago
Court Ruling
BEARISH ★ 6/10
$22.21 $22.51▼ −1.35%▲ +11.25%$22.25 (−0.18%)
Feb 24, 2026
31w ago
Court Ruling
NEUTRAL ★ 1/10
$22.66 $22.03▼ −2.78%▲ +2.21%$22.25 (−1.81%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (38h 36m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access